Sandbox Reserved 1652: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Chloe Reynas (talk | contribs) No edit summary |
Chloe Reynas (talk | contribs) No edit summary |
||
| Line 69: | Line 69: | ||
== Implication of TRPV1 in the treatment of pain == | == Implication of TRPV1 in the treatment of pain == | ||
In 2011 Qutenza (NeurogesX) patch containing 8% of capsaicin has been markered in France and indicated in the | In 2011 Qutenza (NeurogesX) patch containing 8% of capsaicin has been markered in France and indicated in the [https://en.wikipedia.org/wiki/Neuropathic_pain neuropathic pain]. | ||
The absorption through the skin of these creams generated partial desensitization of the nerve endings. This is the cause of a decrease in painful sensations.<ref name="TRPV1 dans les neuropathies douloureuses - Des modèles animaux aux perspectives thérapeutiques">A. Danigo, L. Magy, et C. Demiot, « TRPV1 dans les neuropathies douloureuses - Des modèles animaux aux perspectives thérapeutiques », médecine/sciences, vol. 29, no 6‑7, Art. no 6‑7, juin 2013, doi: 10.1051/medsci/2013296012.</ref> | The absorption through the skin of these creams generated partial desensitization of the nerve endings. This is the cause of a decrease in painful sensations.<ref name="TRPV1 dans les neuropathies douloureuses - Des modèles animaux aux perspectives thérapeutiques">A. Danigo, L. Magy, et C. Demiot, « TRPV1 dans les neuropathies douloureuses - Des modèles animaux aux perspectives thérapeutiques », médecine/sciences, vol. 29, no 6‑7, Art. no 6‑7, juin 2013, doi: 10.1051/medsci/2013296012.</ref> | ||
